Clarify Pharma PLC

AQSE Growth Market -
Clarify seeks to develop a business concentrating on high potential and fast-growing biotech and life science companies that perform research or produce neuro-pharmaceutical drug development platforms. The focus will be on businesses that advance medicines based on psychedelic substances through rigorous science and clinical trials.
Symbol Ccy Code Bid Ask Mid Previous Close Volume Last Traded
PSYC GBX 2.5 2.8 2.65 2.65 600 12.10.21

MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.

Key Information

  
Market Cap: £7,875,668
ISIN:GB00BMCD8M81
Par:0.001
Inst Type:Ordinaries
Symbol:PSYC
MIFID Status:MTF
Tradable securities in issue:297,195,000
Sector:Pharmaceuticals & Biotechnology
% price change since listing:-7.83%
% daily price change:0.00%

Latest Trades

Date & Time Volume Price
12.10.21  |  13:13:176002.5059
28.09.21  |  14:58:3410002.5149
28.09.21  |  14:15:5210500002.65
28.09.21  |  14:15:3510500002.65
02.07.21  |  10:04:5039282.5475
30.06.21  |  10:50:0156942.5475
23.06.21  |  08:20:3063782.525
18.06.21  |  15:33:593000002.4
17.06.21  |  16:02:308000002.42
17.06.21  |  16:02:278000002.42

Latest Announcements

Date & Time Title
31.08.21  |  07:00:00Clarify Pharma PLC - Clarify Pharma Interim Results
17.08.21  |  07:00:00Clarify Pharma PLC - Clarify Pharma Makes First Capital Investment
28.07.21  |  07:00:00Clarify Pharma PLC - Correction to the Admission Document
11.06.21  |  13:49:00Clarify Pharma PLC - TR1 Notification of major interest in shares
11.06.21  |  07:00:00Clarify Pharma PLC - Clarify's Admission to the AQSE Growth Market

Address

Business Address

Clarify Pharma PLC, 9th Floor, 16 Great Queen Street, London, WC2B 5DG, England.

Email: nl@nlconsulting.co.uk

Phone: +44 207 183 7407

Registered Address

9th Floor, 16 Great Queen Street, London, WC2B 5DG, England.

Contacts

Corporate Adviser

First Sentinel Corporate Finance, 72 Charlotte Street, London , United Kingdom.

Email: brian@first-sentinel.com

Phone: 020 3752 3118

Registrar

Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol, BS13 8AE, United Kingdom.

Email: web.queries@computershare.co.uk

Phone: 0370 703 6191

Research


I'm sorry there is no research for this company.